Home
Exosome Diagnostics

Exosome Diagnostics Market Share Analysis for June 2026

our non-invasive liquid biopsies can determine a patient's risk of high-grade prostate cancer. they are clinically validated to provide actionable results. learn more.

Health > Biotechnology and Pharmaceuticals

Domainexosomedx.com

Year Founded2008

Employees51 - 200

Annual Revenue$15M - $25M

Exosome Diagnostics

Exosome Diagnostics (including company regionals)

exosomedx.com

See more website traffic and engagement information

Exosome Diagnostics Revenue up to June 2026 is 15M - 25M

revenue generated by Exosome Diagnostics top domains

Exosome Diagnostics top domains revenue over 3 years

Revenue for Exosome Diagnostics top domains

exosomedx.com15M - 25M

See more with Sales Intelligence

Total visits to Exosome Diagnostics's top domains

Understand Exosome Diagnostics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

exosomedx.com2.6K

See more with Sales Intelligence

Avg. visit duration in Exosome Diagnostics's top domains

Analyze Exosome Diagnostics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

exosomedx.com00:00:26

See more with Sales Intelligence

Avg. pageviews on Exosome Diagnostics's top domains

See how Exosome Diagnostics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

exosomedx.com1.38

See more with Sales Intelligence

Exosome Diagnostics top competitors by domain

Top similar sites in June 2026, ranked by their affinity

biocentury.comCompany NameBioCenturyEmployees51 - 200HQUnited States, California, Redwood CityAnnual revenue$15M - $25MTotal visits65.9KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Exosome Diagnostics

These are the website technologies, by industry, used by Exosome Diagnostics top domains

Advertising (7)

DoubleClick

Conversion & Analytics (6)

Google Analytics

Content Management System (4)

WordPress

Social (4)

Facebook Connect

More Technologies

10

See all

News & Signals from Exosome Diagnostics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCarefirst Inc. partners with Exosome.CareFirst holdings enters into a strategic partnership with Exosome Diagnostics.

NewsExosome launches Exosome.MINNEAPOLIS, February 11, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has recently published a paper entitled Exosome-based Liquid Biopsies in Cancer: Opportunities and Challenges (Yu, W et al.), in the highly rated peer-reviewed journal, Annals of Oncology ( link ).

NewsExosome is developing liquid biopsy test for analyzing cancer diseases.And finally, Exosome Diagnostics is developing a liquid biopsy test for analyzing cancer diseases.